Back
Rhythm Pharmaceuticals Stock Price Chart
Free Stock Analysis: See What Your Stock is Really Worth
Analyze Any Stock Free
Sell
26
RYTM
Rhythm Pharmaceuticals
Last Price:
$53.96
Seasonality Move:
-21.98%
7 Day Trial
ALL ACCESS PASS
$
7
Free Stock Analysis Report: See The True Value of Any Stock
Analyze Any Stock Free-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RYTM is experiencing slight selling pressure.
Rhythm Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 57.95 | Sell |
| 20-day SMA: | 56.61 | Sell |
| 50-day SMA: | 58.01 | Sell |
| 200-day SMA: | 47.99 | Buy |
| 8-day EMA: | 57.13 | Sell |
| 20-day EMA: | 57.26 | Sell |
| 50-day EMA: | 56.52 | Sell |
| 200-day EMA: | 49.27 | Buy |
Rhythm Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.04 | Sell |
| Relative Strength Index (14 RSI): | 42.66 | Sell |
| Chaikin Money Flow: | -172480 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (55.21 - 58.49) | Sell |
| Bollinger Bands (100): | (48.36 - 59.02) | Buy |
Rhythm Pharmaceuticals Technical Analysis
| Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | Jan 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | 10 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Rhythm Pharmaceuticals Stock
Is Rhythm Pharmaceuticals Stock a Buy?
-
Rhythm Pharmaceuticals share price is 54.89 while RYTM 8-day simple moving average is 57.95, which is a Sell signal.
-
The stock price of RYTM is 54.89 while Rhythm Pharmaceuticals 20-day SMA is 56.61, which makes it a Sell.
-
Rhythm Pharmaceuticals 50-day simple moving average is 58.01 while RYTM share price is 54.89, making it a Sell technically.
-
RYTM stock price is 54.89 and Rhythm Pharmaceuticals 200-day simple moving average is 47.99, creating a Buy signal.
RYTM Technical Analysis vs Fundamental Analysis
Sell
26
Rhythm Pharmaceuticals (RYTM)
is a Sell
Is Rhythm Pharmaceuticals a Buy or a Sell?
-
Rhythm Pharmaceuticals stock is rated a SellThe current Rhythm Pharmaceuticals [RYTM] share price is $54.89. The Score for RYTM is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
Rhythm Pharmaceuticals Stock Info
Market Cap:
3.4B
Price in USD:
54.89
Share Volume:
495.4K
Rhythm Pharmaceuticals 52-Week Range
52-Week High:
68.58
52-Week Low:
35.17
Sell
26
Rhythm Pharmaceuticals (RYTM)
is a Sell
Rhythm Pharmaceuticals Share Price Forecast
-
What is the Rhythm Pharmaceuticals stock price today?The Rhythm Pharmaceuticals stock price is 54.89 USD today.
-
Will RYTM stock go up or go down?Rhythm Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Rhythm Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Rhythm Pharmaceuticals is overvalued.
Is Rhythm Pharmaceuticals Stock a Buy?
-
Rhythm Pharmaceuticals share price is 54.89 while RYTM 8-day exponential moving average is 57.13, which is a Sell signal.
-
The stock price of RYTM is 54.89 while Rhythm Pharmaceuticals 20-day EMA is 57.26, which makes it a Sell.
-
Rhythm Pharmaceuticals 50-day exponential moving average is 56.52 while RYTM share price is 54.89, making it a Sell technically.
-
RYTM stock price is 54.89 and Rhythm Pharmaceuticals 200-day simple moving average is 49.27, creating a Buy signal.
Fundamental Analysis of Rhythm Pharmaceuticals
Is Rhythm Pharmaceuticals a good investment?
-
Analysts estimate an earnings increase this quarter of $0.25 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.62 per share, and an increase next year of $2.04 per share.
Technical Analysis of Rhythm Pharmaceuticals
Should I short Rhythm Pharmaceuticals stock?
-
RYTM Moving Average Covergence Divergence (MACD) indicator is -0.04, suggesting Rhythm Pharmaceuticals is a Sell
-
Rhythm Pharmaceuticals Relative Strength Index (RSI) is 42.66, which suggest Rhythm Pharmaceuticals is oversold
-
The Bollinger Bands (25) for Rhythm Pharmaceuticals is (55.21 - 58.49), which suggest Rhythm Pharmaceuticals is a Buy
-
The Bollinger Bands (100) for Rhythm Pharmaceuticals is (48.36 - 59.02), which suggest Rhythm Pharmaceuticals is a Buy
* Rhythm Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.